...
首页> 外文期刊>Biomedicine & preventive nutrition >Antihyperglycemic effect of syringic acid on attenuating the key enzymes of carbohydrate metabolism in experimental diabetic rats
【24h】

Antihyperglycemic effect of syringic acid on attenuating the key enzymes of carbohydrate metabolism in experimental diabetic rats

机译:丁香酸的降血糖作用减弱实验性糖尿病大鼠糖代谢关键酶的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetes mellitus is one of the most common endocrine entities, which coexist with defect in carbohydrate metabolism. The Indian traditional system of medicine prescribed plant phytochemical therapies for diseases including diabetes mellitus. The present study was aimed to evaluate the therapeutic potential of syringic acid (SA) by assaying the activities of key enzymes of carbohydrate metabolism in experimental diabetic rats. Diabetes was induced into male albino Wistar rats by intraperitoneal administration of alloxan (150mg/kg). SA was administered to diabetic rats intragastrically at 25, 50 and 100mg/kg b.w daily once for 30days. The levels of plasma glucose, insulin, hemoglobin (Hb), glycated hemoglobin (HbA1c) and glycogen, levels of carbohydrate metabolic enzymes, liver and kidney markers were evaluated. Oral administration of SA (50mg/kg) for 30days, dose dependently improved the glycemic status in diabetic rats. The levels of insulin, Hb and glycogen increased with significant decrease in glucose and HbA1c levels in SA treated rats. The altered activities of carbohydrate metabolic enzymes, hepatic and renal marker were restored to near normal. Histopathological analysis of pancreas revealed that treatment with SA reduced the pancreatic damage induced by alloxan and stimulated β-cell regeneration in diabetic rats. The present findings suggest the antihyperglycemic effect of SA and its therapeutic potential for the management of diabetes.
机译:糖尿病是最常见的内分泌实体之一,与碳水化合物代谢缺陷共存。印度的传统医学系统规定了针对包括糖尿病在内的疾病的植物植物化学疗法。本研究旨在通过测定实验性糖尿病大鼠中糖代谢的关键酶的活性来评估丁香酸(SA)的治疗潜力。通过腹膜内施用四氧嘧啶(150mg / kg)将糖尿病诱导为雄性白化Wistar大鼠。每天以25、50和100mg / kg b.w的腹腔内剂量对糖尿病大鼠进行一次SA,持续30天。评估血浆葡萄糖,胰岛素,血红蛋白(Hb),糖化血红蛋白(HbA1c)和糖原的水平,碳水化合物代谢酶的水平,肝和肾标志物的水平。口服SA(50mg / kg)30天,剂量依赖性地改善了糖尿病大鼠的血糖状态。在SA处理的大鼠中,胰岛素,血红蛋白和糖原的水平随着葡萄糖和HbA1c水平的显着降低而增加。碳水化合物代谢酶,肝和肾标志物的活性改变恢复到接近正常水平。胰腺的组织病理学分析表明,SA治疗可以减轻四氧嘧啶引起的胰腺损伤,并刺激糖尿病大鼠的β细胞再生。目前的发现表明SA的降血糖作用及其对糖尿病治疗的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号